2015
DOI: 10.1016/j.vascn.2015.03.003
|View full text |Cite
|
Sign up to set email alerts
|

A non-human primate model for investigating drug-induced risk of orthostatic hypotension and sympathetic dysfunction: Preclinical correlate to a clinical test

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 20 publications
0
4
0
Order By: Relevance
“…8C and D ). The mean responses in tanezumab treated groups were typical, and similar to vehicle, as evidenced by a transient decrease in BP induced by the head-up tilt, which returned to pretilt (supine) levels within 20–30 s ( Figure 8C ) ( Bhatt et al , 2015 ). Isolated incidences of OH were observed during the 6-month treatment phase ( Table 4 ) and are detailed below.…”
Section: Resultsmentioning
confidence: 68%
See 3 more Smart Citations
“…8C and D ). The mean responses in tanezumab treated groups were typical, and similar to vehicle, as evidenced by a transient decrease in BP induced by the head-up tilt, which returned to pretilt (supine) levels within 20–30 s ( Figure 8C ) ( Bhatt et al , 2015 ). Isolated incidences of OH were observed during the 6-month treatment phase ( Table 4 ) and are detailed below.…”
Section: Resultsmentioning
confidence: 68%
“…In light of these morphologic changes and previously reported biochemical effects of anti-NGF ( Bjerre et al , 1975 ; Goedert et al , 1978 ), it was of interest to assess the function of the SNS in these animals. Radiotelemetry was used to assess ambulatory cardiovascular parameters and a validated nonclinical correlate of the clinical OH test was used to assess SNS function while undergoing a tilt challenge ( Bhatt et al , 2015 ). In these studies, one cohort of animals was treated the same way as in the morphology studies (approximately 5 times the clinical exposure) and another was dosed at a much higher level giving plasma exposure ∼900 times that achieved in the clinic.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations